# K020820: Microscan Microstep Plus Panel New Antimicrobial - Cefuroxime

- Pathway: 510(k) (Traditional)
- Applicant: Dade Behring, Inc.
- Decided: May 9, 2002 after 57 days
- Product code: JWY (Manual Antimicrobial Susceptibility Test Systems)
- Device class: 2
- Regulation: 21 CFR 866.1640
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K963641 (1996). 1 ancestor in all.
1 later device descends from it; 1 cites it directly.
0 of 3 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K963641: Streptococcus Mic Panel, Dade Microscan, Inc. (1996) Summary page 1.

## Most influential descendants
- K063053: Microscan Microstrep Plus Panel Cefuroxime (0.12-8 MCG/ML) (2006), 0 descendants of its own

## Indications for use
The MicroScan® MICroSTREP plus™ Panel is used to determine quantitative and/or qualitative antimicrobial agent susceptibility of colonies grown on solid media of aerobic streptococci, including Streptococcus pneumoniae. After inoculation, panels are incubated for 20 — 24 hours at 35°C +/- 1°C in a non-CQO2 incubator, and read visually according to the Package Insert. This particular submission is for the addition of the antimicrobial Cefuroxime at concentrations of 0.12 to 8 mcg/ml to the test panel The organisms which may be used for Cefuroxime susceptibility testing in this panel are: Streptococcus pneumoniae

Source page: https://510kreport.com/device/K020820
Methodology: https://510kreport.com/methodology